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Computational fluid dynamicsTreatment of intracranial aneurysms with flow-diverting stents is a safe and minimally invasive tech-
nique. The goal is stable embolisation that facilitates stent endothelialisation, and elimination of the
aneurysm. However, it is not fully understood why some aneurysms fail to develop a stable clot even
with sufficient levels of flow reduction. Computational prediction of thrombus formation dynamics can
help predict the post-operative response in such challenging cases. In this work, we propose a newmodel
of thrombus formation and platelet dynamics inside intracranial aneurysms. Our novel contribution com-
bines platelet activation and transport with fibrin generation, which is key to characterising stable and
unstable thrombus. The model is based on two types of thrombus inside aneurysms: red thrombus
(fibrin- and erythrocyte-rich) can be found in unstable clots, while white thrombus (fibrin- and
platelet-rich) can be found in stable clots. The thrombus generation model is coupled to a CFD model
and the flow-induced platelet index (FiPi) is defined as a quantitative measure of clot stability. Our model
is validated against an in vitro phantom study of two flow-diverting stents with different sizing. We
demonstrate that our model accurately predicts the lower thrombus stability in the oversized stent sce-
nario. This opens possibilities for using computational simulations to improve endovascular treatment
planning and reduce adverse events, such as delayed haemorrhage of flow-diverted aneurysms.
 2019 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction ysms: white thrombus, rich in fibrin and platelets (Fischer et al.,Treatment of large and wide-necked intracranial aneurysms of
the anterior circulation with flow-diverting stents is safe and effec-
tive (Becske et al., 2013; Byrne and Szikora, 2012; Fischer et al.,
2012). However, post-treatment rupture after seemingly success-
ful treatment, reported in almost 2% of cases (Byrne and Szikora,
2012; Kulcsár and Szikora, 2012), is associated with high risks of
mortality and morbidity. There is a growing consensus that assess-
ment of thrombus composition must successfully predict flow
diverter (FD) performance (Chow et al., 2012; Fischer et al.,
2012; Kulcsár et al., 2011; Kulcsár and Szikora, 2012; Kuzmik
et al., 2013; Turowski et al., 2011; Xiang et al., 2014). Two types
of thrombi have been identified from autopsy studies of aneur-2012; Turowski et al., 2011), and red thrombus. Red thrombus is
characterised by: (i) less enmeshed platelets (Fischer et al., 2012;
Turowski et al., 2011), (ii) not facilitating the formation of a neoin-
timal layer (Kadirvel et al., 2014; Szikora et al., 2015), (iii) being
prone to continuous fibrinolysis and renewal (Turowski et al.,
2011; Undas and Ariëns, 2011; Weisel and Litvinov, 2008), and
(iv) inducing autolytic activities in the wall resulting in weakening
of the wall and ultimately rupture (Fischer et al., 2012; Kulcsár
et al., 2011; Turowski et al., 2011). Non-organised red thrombi
after flow diversion has been suggested as a potential predictor
for post-treatment rupture (Chow et al., 2012; Kuzmik et al.,
2013; Fischer et al., 2012; Kulcsár et al., 2011; Kulcsár and
Szikora, 2012; Turowski et al., 2011).
While the mechanisms of FD-induced thrombosis are not well
understood, there is a consensus that blood flow stasis induced
by flow diversion is the dominant driver of the clot formation in
intracranial aneurysms. The clots found in flow-diverted aneur-
ysms are closer in structure to those clots formed under stagnant
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induced arterial thrombosis (Kulcsár et al., 2011; Park et al., 2017;
Tan and Lip, 2003; Wolberg et al., 2012). In flow stasis, secretion of
tissue factor by endothelium (Bodnár et al., 2014), white blood
cells (Bodnár et al., 2014), and hypoxic platelets (Bodnár et al.,
2014; Versteeg et al., 2013); and, secretion of platelet activating
factors by endothelium (de Sousa et al., 2015) and hypoxic red
blood cells (Bodnár et al., 2014; Aida and Shimano, 2013;
Shimano et al., 2010) are associated with fibrin generation and pla-
telet activation, the two major components of clot formation.
Regions with low shear flow and high residence time promote pla-
telet activation and adhesion (de Sousa et al., 2015; Ouared et al.,
2008), and stabilisation of platelet aggregates (Nesbitt et al.,
2009). They also enhance platelet-fibrin and platelet-
endothelium interactions (Ouared et al., 2008). It has been hypoth-
esised that platelets can be activated in high-shear regions near the
FD struts or because of blood contact with the FD wires (Heller
et al., 2013; Taylor et al., 2017). Such effects are avoided by dual
antiplatelet therapies (Heller et al., 2013; Tan and Lip, 2003;
Taylor et al., 2017) or modification/coating of the wires (Girdhar
et al., 2018, 2019; Martínez-Galdámez et al., 2017) to minimise
the risk of thromboembolic events distal to the aneurysm (Heller
et al., 2013; Tan and Lip, 2003; Taylor et al., 2017). Hence, despite
a diverse set of initiation mechanisms, flow stasis can be the nexus
between them all. In our proposed model we focus on flow stasis as
the pathway to thrombus formation.
While extensive computational investigations have focused on
modelling thrombosis in flow systems, few studies have simulated
coupled haemodynamics and biochemistry in flow-diverted aneur-
ysms (Ngoepe and Ventikos, 2016; Ou et al., 2017). Taking thrombin
concentration as a surrogate for thrombosis, Ngoepe and Ventikos
(2016) simulated clot growth in aneurysms after flow diversion,
and an assumption was made that thrombin generation originated
on theendothelialwall due to tissuedamage.Ouet al. (2017) focused
on stasis-induced expression on blood-borne tissue factor as the ini-
tiator and simulated fibrin generation inside the flow-diverted
aneurysm. Although these studies presented promising results on
simulation-based prediction of FD-induced thrombosis, they did
not predict the platelet composition of the clot or its stability. Our
model is the first to attempt computational thrombus stability anal-
ysis in realistic three-dimensional aneurysms after flow-diversion.
The objective of this study is to create a coupled flow and
thrombosis model capable of predicting the stability of the clot
that forms after flow diversion. A computational thrombosis model
must consider estimation of the clot extent and stability in terms of
composition of its structural components, i.e. fibrin and platelets.
We consider FD-induced stasis as a surrogate for all the above
mentioned thrombosis initiation mechanisms and simultaneously
model thrombin and fibrin generation, and platelet activation
and aggregation in stagnation regions. We validate our modelFig. 1. Left panel: schematic representation of platelet transport to the clotting site. Righ
study.against an in vitro experiment performed in Gester et al. (2016),
in which thrombus formation was examined in an aneurysm phan-
tom treated with FD’s of different sizes.2. Materials and methods
2.1. Model of thrombosis after flow diversion
Our model is based on bulk initiation and propagation of throm-
bosis due to flow stasis. Increased flow residence time, decreased
flow velocity, decreased shear rate, and decreased vorticity have
been used to characterise flow stasis in aneurysms (Cebral et al.,
2014; Ouared et al., 2016; Rayz et al., 2010). When compared with
thrombosed regions, velocity, vorticity, and shear rate were
reported to be 2.8 times larger in non-thrombosed regions of
elastase-induced aneurysms in animal models (Cebral et al.,
2014). Based on a harmonic analysis of shear rate waves in ten
aneurysms, de Sousa et al. (2015) determined 25 s1 as the thresh-
old for thrombosis. Rayz et al. (2010) showed that thrombus
deposits in aneurysmal regions with a residence time greater than
18.22 ± 11 s. We therefore assumed thrombosis to initiate and pro-
gress in prothrombotic regions of the aneurysm after flow diversion,
i.e., regions with time-averaged shear rate smaller than
SRt ¼ 25 s1 (de Sousa et al., 2015) and residence time greater than
RTt ¼ 5 s (Rayz et al., 2010).
We considered four biochemically-coupled events that result in
a clot of fibrin mesh and aggregated platelets: (i) Thrombin genera-
tion occurs by conversion of prothrombin to thrombin on the sur-
face of resting and activated platelets, where the reaction kinetics
are faster for activated platelets. Also considered is thrombin inhi-
bition by its primary plasma inhibitor (anti-thrombin), in the
absence of heparin catalysis. (ii) Fibrin generation occurs in the
presence of thrombin, which converts fibrinogen to fibrin mono-
mers. We did not consider further polymerisation of the fibrin
monomers. (iii) Platelet activation occurs when resting platelets
become activated by exposure to thrombin or other activated pla-
telets. The latter mechanism was a surrogate for activation by ago-
nists released from other activated platelets (Kuharsky and
Fogelson, 2001). (iv) Platelet aggregation in the presence of fibrin
takes place when platelets attached to the fibrin network aggregate
to form bound platelets. Bound platelets were assumed to activate
prothrombin and other resting platelets. Our model included five
biochemical species: prothrombin (PT), thrombin (TH), anti-
thrombin (AT), fibrinogen (FG), fibrin (FI). Three categories of pla-
telets; resting platelets (RP), activated platelets (AP), and fibrin
bound aggregated platelets (BP) were considered. A schematic rep-
resentation of the biochemical species and reactions is given in
Fig. 1. Mathematical description of our thrombosis model and the
governing equations are provided in the Supplementary Material.t panel: schematic representation of the clotting reaction network modelled in this
Table 1
Haemodynamic quantifications before and immediately after FD placement, averaged
over time and the sac. Values in parentheses indicate changes from the pre-FD
quantity.
Velocity Residence time Shear rate
[m/s] [s] [s1]
Before FD placement 0.043 0.649 89.66
After FD placement
FD-4.0 0.003(93%) 7.504(+1,056%) 5.786(94%)
FD-4.5 0.008(81%) 1.947(+200%) 18.59(79%)
A. Sarrami-Foroushani et al. / Journal of Biomechanics 91 (2019) 7–13 92.2. Flow induced Platelet index (FiPi)
We defined the flow induced platelet index (FiPi) as the relative
difference of the platelet concentration between a closed and an
open system:
P ¼ C
open
bp  Cclosedbp
Cclosedbp
¼ C
open
bp
Crp;0 þ Cap;0  1: ð1Þ
In Eq. (1), Crp;0 and Cap;0 are initial concentrations of resting and acti-
vated platelets in the clot-free blood, respectively. FiPi quantifies
the effect of blood flow on transport of platelets to and from the site
of clot formation and consequently on the final platelet content of
the formed clot. As shown in Fig. 2, in a closed system with no
inflow or outflow, we assumed the concentration of bound platelets
in a formed clot to be equal to the summation of the concentrations
of resting and activated platelets at the initial state before any clot
formed. However, in an open system, where blood can flow over
and through the forming clot, the final concentration of bound pla-
telets in the formed clot would differ from that in closed systems. In
flow-diverted aneurysms, it has been hypothesised that the flow
entering the sac brings platelets into contact with the forming clot
and promotes formation of a higher platelet content clot (Xiang
et al., 2014).
2.3. Computational model validation
Gester et al. (2016) evaluated intra-aneurysmal FD-induced
thrombus formation. Two FD’s of same type with two diameters
were deployed in a silicone phantom of a simplified lateral aneur-
ysm; one of the FD’s had a diameter of 4.00 mm (FD-4.0) the other
was oversized with a diameter of 4.50 mm (FD-4.5). The phantom
aneurysm was spherical with an inner diameter of 6.4 mm and a
neck width of 6.0 mm. The tubular parent vessel had an inner
diameter of 4.2 mm with an angle of 120 at the aneurysm neck.
Blood from the cervical artery of slaughter house pigs were circu-
lated in the phantom model. Particle imaging velocimetry (PIV)
and Doppler sonography were performed to monitor the flow
inside aneurysm. The FD-induced intra-aneurysmal clots were
qualitatively evaluated once the sonography signal no longer
existed (i.e., 10–12 h after the experiments started). In the aneur-Fig. 2. The first two columns represent the concept of the flow-induced platelet inde
concentration of platelets in the container before clotting occurred. In an open system, m
attach to the clot and increase the clot platelet content. The third column shows the ph
(second row) and FD-4.5 (third row).ysm treated with FD-4.0, a red cap-shaped clot was observed,
mostly consisting of organised and platelet-rich clot formed with
a growth direction opposite to the entering flow jet. In the aneur-
ysm treated with the oversized stent, FD-4.5, a less platelet-rich
clot filling almost the entire sac with no clear growth direction
was observed with only a rigid (platelet-rich) region near the cen-
ter of the aneurysm. We built computer models of the phantom
experiments and compared computational simulations of the FD-
induced thrombosis against in vitro observations reported in
Gester et al. (2016). Details on the computer models and the
numerical simulations are presented in the Supplementary
Material.3. Results
3.1. Aneurysmal haemodynamics before/after flow diversion
Table 1 shows pre- and post-treatment haemodynamic quan-
tifications based on the flow simulations before the thrombosis
was activated (the first set of simulations). Both FD configurations
induced flow stasis in the aneurysm sac. Fig. 3 shows intra-
aneurysmal haemodynamics along the aneurysm sagittal mid-
plane before and immediately after FD deployment before any clot
formed. To enable a qualitative comparison with the PIV measure-
ments made in Gester et al. (2016), we ran pulsatile flow simula-
tions, with no chemical reaction, and presented velocity contour
plots at the peak systole. In Fig. 3, shear rate and residence time
contour plots are taken from steady-state simulations and repre-
sent the time-averaged values.x (FiPi). In a closed system, the platelet content of the clot is equal to the initial
ore platelets are advected with the blood flow to the clotting site, where they can
antom from Gester et al. (2016) (first row) and the computer models with FD-4.0
Fig. 3. Intra-aneurysmal haemodynamic quantification before and immediately after FD deployment. Velocity quantifications were made at the peak systole to enable
comparisons with PIV measurements made in Gester et al. (2016). Flow direction is indicated with a white arrow in the top left panel and is the same in other panels.
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The thrombosis initiation criteria (SR < 25 s1 and RT > 5 s)
were not met in the simulations of intra-aneurysmal flow before
FD placement, therefore, as expected, no clot formed in the aneur-
ysm sac. According to previous studies (Anand et al., 2003, 2008),
we assumed the clot to be formed in regions where the fibrin con-
centration is greater than 600 nM. In Fig. 4 (first row), the white
iso-lines, drawn at fibrin concentrations of 600 nM, show the
thrombus front. The dark red is associated with fibrin concentra-
tions greater than 3500 nM, showing an almost complete conver-
sion of plasma fibrinogen into fibrin. In agreement with (Gester
et al., 2016), both FD’s developed a clot that filled nearly the entire
sac. In the FD-4.0 case, more pronounced formation and anchorage
of fibrin strands to the proximal region of the FD were reported in
the phantom experiments once the clot began to form. A proximal-
to-distal direction of clot growth was reported in the FD-4.0 case,
as opposed to no clear growth direction in the case treated with
FD-4.5. Based on the transient results (see fibrin concentration
contour plots at t ¼ 10 s in Fig. 4), we observed that in the aneur-
ysm treated with FD-4.0, the clot formed from the aneurysm prox-
imal region and grew in a direction opposite to the entering flow
jet direction to fill the aneurysm. In the aneurysm treated with
FD-4.5, there was also a clot forming in the central part of the
aneurysm (the central recirculation zone), growing with no pre-
ferred direction. We also observed a thicker band of high fibrin
concentration started from the proximal region of FD and extended
across the sac to the upper distal wall.
Fig. 4 (second row) shows contour plots of FiPi used to measure
the effect of blood flow on the clot platelet content. In the FD-4.0
case, our results showed a platelet-rich clot (FiPi > 0.15) covering
the entire aneurysm neck and extended towards the upper wall.However, in the FD-4.5 case, formation of the platelet-rich clot
was limited to the central region of the sac. We observed a less
platelet-rich clot at the proximal region of the aneurysm (in both
cases) and in a small region at the centre of the platelet-rich clot
formed in the centre of the aneurysm treated with the oversized
FD. This observation agrees with the in vitro study (Gester et al.,
2016), where a clot with a generally higher platelet content was
reportedly induced by the FD-4.0, and regions with high platelet
content around the central vortex were reported in the FD-4.5 case.4. Discussion
4.1. Thrombus formation and model validation
The in vitro study (Gester et al., 2016) compared the effects of
flow diversion by two stents in the same silicone phantom. In both
cases, the phantom was filled with thrombus at the end of the
experiment, at which point the authors removed the silicone
model and provided snapshots of the induced clots. To enable com-
parisons with the in vitro experiments (Gester et al., 2016), we set
a threshold on FiPi, the measure of platelet content, and extracted
from this the platelet-rich clot morphology. The morphology of the
clots obtained from our model showed the best qualitative agree-
ment with snapshots of the phantom experiment, when we used
FiPi > 0:15 as a threshold. Fig. 4, the third row, shows our model
predictions of the morphology of the platelet-rich clot and snap-
shots of the phantoms taken from Gester et al. (2016). While we
emphasise that FiPi > 0:15 is not a generalised threshold, we
explored what happens to the morphology of the platelet-rich clots
when we set a different threshold on FiPi. We examined thresholds
FiPi > 0:10 and FiPi > 0:20. We used the Dice similarity coefficient
Fig. 4. Simulation of thrombosis in flow diverted aneurysms. In the first two rows, fibrin concentration contour plots are presented on the aneurysm sagittal mid-plane. In the
first row, the white solid line represents a concentration of 600 nM. In the third row, for each flow-diverter, model predictions of the high-platelet content clot morphology
(left) are compared against snapshots of the clots (right) from in vitro observations reported in Gester et al. (2016). The snapshots and the model predictions are presented in
the same spatial scale and dotted lines are used to show the clot extent above the FDs. Flow direction is indicated with a white arrow in the top left panel and is the same in
other panels.
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gies produced by the new thresholds and the reference morphol-
ogy extracted from FiPi > 0:15. High DSC scores 92.0% and 92.9%
were achieved when the morphologies extracted from FiPi > 0:10
and FiPi > 0:20 thresholds was compared to the reference mor-
phology, respectively. This demonstrates that thresholding FiPi is
a robust way to predict.
Location of the clot and the growth direction. In both cases,
in vitro experiments (Gester et al., 2016) showed that the clot
started to form on the proximal wall. With FD-4.5, the course of
thrombosis continued by formation of fibrin as a result of stagna-
tion of blood at the centre sac, i.e., the central vortex. Fibrin then
filled the aneurysm without a clear growth direction. With FD-
4.0, the clot grew layer-by-layer and filled the aneurysm towards
the distal wall. Our thrombosis model correctly predicted the loca-
tions of clot deposition and the growth directions reported in these
in vitro experiments. Cebral et al. (2014) reported a layer-wise
growth of clot from regions with smaller velocity, shear rates,
and vorticity, i.e., the dome, towards the flow-diverted aneurysm
neck. These results show that the thresholds we found based on
residence time and shear rate were valid and that our model pre-
dicted realistic thrombi deposition location and growth direction.
Location of the high platelet content clot. In the FD-4.0 case, sim-
ulations indicated a transformation from inertia-driven to shear-
driven flow (Fig. 3). Flow stasis along the proximal wall resulted
in rapid formation of a less platelet-rich clot. However, during
the course of thrombosis, the shear-driven, well-distributed blood
flow promoted the attachment of platelets to the forming clot. This
finally helped to form a homogeneous platelet-rich clot almost in
the entire aneurysm. However in the aneurysm treated with the
oversized stent FD-4.5, inertial effects persisted in the post-
treatment flow and circulation in the aneurysm sac was observed
(Fig. 3). Although less pronounced than in the FD-4.0, extensive
stasis along the proximal wall resulted in the rapid formation ofa less platelet-rich clot. We also observed the formation of a clot
in the central vortex. In contrast to FD-4.0, the inertia-driven flow
jet was not slow enough to promote platelet attachment. This flow
pattern resulted in a heterogeneous clot with a higher platelet con-
centration limited to the outer layers of clot initially formed in the
central vortex (Fig. 4). These findings agreed qualitatively with the
experimental observations in Gester et al. (2016) and provided
support to the hypothesis that rapid formation of clot in regions
of extensive stasis results in a less platelet-rich clot, however, as
the clot grows and interacts with the blood flow, more platelets
come in contact with the forming clot, which results in formation
of a more platelet-rich clot (Kulcsár et al., 2011; Xiang et al., 2014).
Coverage of the aneurysmneck. Formationof a platelet-rich organ-
ised clot over the aneurysm neck is essential to close the aneurysm
and facilitate endothelialisation (Kadirvel et al., 2014; Szikora et al.,
2015). In our simulations, we did not consider surface reactions on
the FD struts. However, in the FD-4.5, we observed the formation
of a thin platelet-rich layer covering the proximal section of the
aneurysmneckandextending to a thicker layer in the central section
of the neck. The distal section of theneck remainedpatent. In the FD-
4.0, we observed a thick platelet-rich layer covering the aneurysm
neck. Similar behaviour was reported in in vitro experiments
(Gester et al., 2016) and also in Kadirvel et al. (2014),Szikora et al.
(2015), where the FD failed to close the sac in real aneurysms. In
the FD-4.5, the clot formed in the central region of the sac was sur-
rounded by a flow jet that prevented a full coverage of the neckwith
a stable clot. The FD-4.0 altered the flow pattern inside the sac and
facilitated layer-wise growth of the clot and finally the full coverage
of the aneurysm neck with a platelet-rich clot.
4.2. Clinical utility
Treatment planning of flow diversion is usually based on the
morphology of the aneurysm (Becske et al., 2013; Fischer et al.,
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ysms and those with a high aspect ratio or complex morphology
are thought to be prone to post-FD haemorrhage (Kulcsár et al.,
2011). Immediately after deployment, the efficacy of the FD is eval-
uated by measuring the reduction of flow into the aneurysmal sac
by angiographic examination. However, post-operative rupture
was reported in several cases with excellent immediate angio-
graphic results after FD deployment (Kulcsár et al., 2011; Kuzmik
et al., 2013; Turowski et al., 2011).
CFD-modellers have suggested different haemodynamic criteria
for predicting successful occlusion of aneurysms after flow diver-
sion. For example, Ouared et al. (2016) reported a minimum reduc-
tion of 35% in the aneurysmmean velocity after flow diversion as a
criterion for predicting successful occlusion. Mut et al. (2015)
reported post-treatment velocity and shear rate of 1.31 cm/s and
16.35 s1, respectively, as criteria for successful aneurysm occlu-
sion. In our simulations, post-treatment haemodynamics in both
FD-4.0 and FD-4.5 cases met the success criteria suggested in the
above studies. However, the two cases developed a clot with differ-
ent qualities. This shows that purely haemodynamic assessments
cannot predict the likelihood of formation of a stable clot. To com-
prehensively assess post-FD occlusion, it is necessary to consider
the potential quality of the FD-induced clot, i.e., whether flow
diversion results in a stable white clot or a red unorganised clot.
Our model showed promise in predicting the biochemical compo-
sition of clot structural components, fibrin and platelets, and thus,
the likelihood of formation of a fibrin and platelet-rich white
thrombi after flow diversion.
Also there is evidence that in aneurysm treatment with FD, for-
mation of a stable white clot over the aneurysm neck and the con-
sequent formation of neo-intimal layer and FD endothelialisation
are of superior importance than FD-induction of the thrombi inside
the aneurysm body (Kadirvel et al., 2014; Szikora et al., 2015).
Cebral et al. (2014) trained a statistical model to predict the local
occlusion based on local haemodynamics and found poorer predic-
tions near the aneurysm neck, when compared to other regions of
the flow diverted aneurysm. This magnifies the utility of models
similar to the one in the present work to further improve person-
alised assessment of aneurysm flow diversion.4.3. Limitations
Low-shear stagnant flow is believed to be the main driver of
thrombosis in flow-diverted aneurysms (Ouared et al., 2016;
Rayz et al., 2010). Dual anti-platelet inhibition regimens are pre-
scribed to minimise, but not eliminate, mechanical high-shear
induced platelet activation in aneurysms treated with FDs (Heller
et al., 2013). In our experiments, we observed blood flow passing
through the FD struts to have a maximum shear rate of about
1000 s1 which was below the shear rate level to activate the pla-
telets (3000 s1Roth, 1991). Maximum shear stress near the struts
was less than 15 Pa in our simulations. According to the Hellums
locus of high shear-induced platelet activation (Hellums, 1994),
such shear stress level requires an exposure time greater than
100 s to activate platelets. Given the near-strut maximum resi-
dence time in our simulations, about 1 s, mechanical activation
does not likely to play a significant role in our experiments.
Although we did not explicitly model mechanical activation, we
analysed the sensitivity of our results to the background platelet
activation level. In this way, we were able to implicitly measure
the effect of putative mechanically activated platelets being
washed into the aneurysm sac. The reference background platelet
activation was 5% in our experiments. For the FD-4.0 case, we
repeated our experiments with 1% and 10% activation levels, main-
taining the concentration of the resting platelets. Changing thebackground activation level did not affect the growth pattern and
the locations of low/high platelet content clot formation and depo-
sition. We also performed a point-wise comparison between FiPi
values throughout the sac. FiPi values were 4 ± 11% lower when
using 1% background platelet activation and 7 ± 18% higher when
10% background activation level was used. We then studied the
sensitivity of the platelet-rich clot morphology to the background
platelet activation level. We set FiPi > 0:15 as a threshold and
extracted the platelet-rich clot morphology. High DSC scores
95.5% and 94.0% were achieved when the reference clot morphol-
ogy (based on 5% background activation) was compared with mor-
phologies obtained from simulations with 1% and 10% background
platelet activation levels, respectively.
The thrombosis model parameters were taken from experimen-
tal literature or relevant computational studies that performed
sensitivity analyses, except the fibrin concentration at which rate
of platelet attachment to the fibrin mesh is half of its maximum
value, Cfi;50. A fixed value of this concentration was used in all
our simulations. A sensitivity analysis was performed with twice
and half of the original concentration, i.e., Cfi;50 ¼ 60 nM. We
observed only small effects on the location and extent of the
thrombus deposition, and on the distribution of platelets in the
final clot. DSC scores of 89.2% and 92.5% were achieved when the
platelet-rich clot morphology obtained with Cfi;50 ¼ 60 nM was
compared to morphologies obtained with two times and half of
this value, respectively. More comprehensive analyses must deter-
mine the sensitivity of clot composition and morphology to the
model parameters.
Due to the computational burden required, the time scale of our
thrombosis model is not representative of the physiological time
scale of FD-induced clot formation and aneurysm occlusion, i.e.,
weeks to months. We relate this to: (i) the extensive simplification
of the thrombosis chemical network, neglecting several molecular
and cellular level phenomena involved in initiation, progression,
and inhibition of thrombosis course after flow diversion, (ii)
neglecting phenomena like lysis, organisation, and contraction of
the clot (iii) neglecting the effect of flow pulsation on the reactions,
especially on the initiation reactions when the clot-related concen-
trations are small, and (iv) the effect of anti-coagulants and anti-
platelets that are both common in flow diversion patients. We
did not consider such anticoagulation in our model.
Augsburger et al. (2009) showed that flow pulsation is not a
major determinant of FD performance in terms of reducing
aneurysmal velocity. Since we were mostly interested in the final
state of the clot and not in phenomena like thrombus breakdown,
we did not consider flow pulsatility and our simulations were per-
formed using a non-pulsatile (steady) inflow boundary condition,
however, the thrombosis model can easily be run with pulsatile
boundary conditions.5. Conclusion
The thrombosis model in the present study was developed to
predict the platelet content distribution in intra-aneurysmal clots
formed after flow diversion. The predictions made by the model
showed qualitative similarities in the clotting pattern and platelet
composition when compared with an in vitro phantom experiment
performed by an independent research group in Gester et al.
(2016). We also compared our model predictions against the liter-
ature on qualitative thrombotic behaviour in aneurysms treated
with flow diverters.Declaration of Competing Interest
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